AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

2.620

-0.050-1.87%

Volume:471.52K

Turnover:1.25M

Market Cap:212.86M

PE:-2.21

High:2.680

Open:2.650

Low:2.610

Close:2.670

52wk High:7.310

52wk Low:2.600

Shares:81.25M

Float Shares:67.00M

Volume Ratio:0.95

T/O Rate:0.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.188

EPS(LYR):-1.186

ROE:-21.85%

ROA:-1.28%

PB:0.57

PE(LYR):-2.21

Loading ...

Overview Company News Filings

Mayne Pharma Group Says Fiscal 2026 H1 Unaudited Revenue Falls 0.5% Year on Year

MT Newswires Live

BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDA

Mayne Pharma Group Ltd - FY Reported Revenue a$408.1 Mln

THOMSON REUTERS

Mayne Pharma Group Ltd - FY a$47M Underlying Ebitda

THOMSON REUTERS

BRIEF-Australian Government Takeovers Panel Made Orders For Cosette

Australian Govt Takeovers Panel - Made Orders Requiring Cosette to Agree to Any Conditions Reasonably Required by Treasurer

THOMSON REUTERS

BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals

Mayne Pharma - Received a Notice of Appeal Filed by Cosette and Its Bidco With Supreme Court of New South Wales, Court of Appea

THOMSON REUTERS

Mayne Pharma - Grounds Set Out in Notice of Appeal Seek to Challenge Court's Findings Regarding Co's FY25 Ebitda, Others

THOMSON REUTERS

Mayne Pharma Group Ltd - Considering Notice of Appeal and Intends to Vigorously Defend Appeal

THOMSON REUTERS

BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing

BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To Retire

ASX Preview: Australian Shares Set to Fall Amid Oil Surge; BlueScope Steel to Pay Special Dividend

MT Newswires Live

Mayne Pharma Group Chair to Retire

MT Newswires Live

Mayne Pharma Group Ltd - Bruce Robinson Has Been Appointed as Non-Executive Chair of Board

THOMSON REUTERS

Mayne Pharma Group Ltd-Change of Director's Interest Notice

THOMSON REUTERS

Mayne Pharma Group Says Net Revenues Fall 5.5% Year on Year for the Period Between July, November

MT Newswires Live

BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26

Mayne Pharma Group - Net Revenues Were a$165 Mln for First 5 Months of FY26

THOMSON REUTERS

Mayne Pharma Group - Underlying Ebitda for First 5 Months of FY26 Was a$11.5M

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MYX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.62,"timestamp":1770959520000,"preClose":2.67,"halted":0,"volume":471517,"delay":0,"changeRate":-0.01872659176029956,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.187574,"marketStatus":"Market Closed","change":-0.05,"latestTime":"02-13 16:12:00 AEDT","open":2.65,"high":2.68,"low":2.61,"amount":1245188,"amplitude":0.026217,"askPrice":2.68,"askSize":31,"bidPrice":2.62,"bidSize":184,"shortable":3,"etf":0,"ttmEps":-1.187574,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":2.67,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0.95316,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.28%","roe":"-21.85%","lyrEps":-1.185711,"volumeRatio":0.95316,"shares":81245827,"dividePrice":0,"high":2.68,"amplitude":0.026217,"preClose":2.67,"low":2.61,"week52Low":2.6,"pbRate":"0.57","psRate":"0.52","week52High":7.31,"institutionHeld":0,"latestPrice":2.62,"committee":0.711628,"eps":-1.187574,"divideRate":0,"volume":471517,"delay":0,"ttmEps":-1.187574,"open":2.65,"prevYearClose":3.11,"prevWeekClose":2.63,"prevMonthClose":2.8,"prevQuarterClose":3.11,"fiveDayClose":2.63,"twentyDayClose":2.9,"sixtyDayClose":4.85,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null},{"date":"2023-08-31","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693440000000,"name":null,"time":"","dateTimestamp":1693404000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607779014","title":"Mayne Pharma Group Says Fiscal 2026 H1 Unaudited Revenue Falls 0.5% Year on Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2607779014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607779014?lang=en_us&edition=fundamental","pubTime":"2026-01-29 12:03","pubTimestamp":1769659432,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said its unaudited revenue for the fiscal 2026 first half came in at AU$212.1 million, down 0.5% from the result it reported in the year-ago period, according to a Thursday Australian bourse filing.Its unaudited underlying earnings before interest, taxes, depreciation, and amortization  for the period clocked in at AU$28.6 million, down 8% year-over-year from AU$31 million in the first half of fiscal year 2025.It cited a lower contribution from the women's health segment, as well as additional investment into sales activities, as drivers behind the underlying EBIDTA.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2607206547","title":"BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2607206547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607206547?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:22","pubTimestamp":1769649758,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Posts FY A$47M Underlying EBITDAJan 29 (Reuters) - Mayne Pharma Group Ltd MYX.AX:FY REPORTED REVENUE A$408.1 MILLIONFY A$47M UNDERLYING EBITDAFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2607729858","title":"Mayne Pharma Group Ltd - FY Reported Revenue a$408.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607729858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607729858?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:44","pubTimestamp":1769640251,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2607729853","title":"Mayne Pharma Group Ltd - FY a$47M Underlying Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2607729853","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607729853?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:44","pubTimestamp":1769640251,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1CL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2605039571","title":"BRIEF-Australian Government Takeovers Panel Made Orders For Cosette","url":"https://stock-news.laohu8.com/highlight/detail?id=2605039571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605039571?lang=en_us&edition=fundamental","pubTime":"2026-01-21 18:30","pubTimestamp":1768991420,"startTime":"0","endTime":"0","summary":"BRIEF-Australian Government Takeovers Panel Made Orders For CosetteJan 21 (Reuters) - AUSTRALIAN GOVERNMENT TAKEOVERS PANEL - MADE ORDERS REQUIRING COSETTE TO AGREE TO ANY CONDITIONS REASONABLY REQUIRED BY TREASURERFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL1KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2605173871","title":"Australian Govt Takeovers Panel - Made Orders Requiring Cosette to Agree to Any Conditions Reasonably Required by Treasurer","url":"https://stock-news.laohu8.com/highlight/detail?id=2605173871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605173871?lang=en_us&edition=fundamental","pubTime":"2026-01-21 14:24","pubTimestamp":1768976697,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YL1KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2603567824","title":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2603567824","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603567824?lang=en_us&edition=fundamental","pubTime":"2026-01-15 13:12","pubTimestamp":1768453957,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette PharmaceuticalsJan 15  - Mayne Pharma Group Ltd MYX.AX:RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEALCONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEALGROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERSFurther company coverage: MYX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2603678690","title":"Mayne Pharma - Received a Notice of Appeal Filed by Cosette and Its Bidco With Supreme Court of New South Wales, Court of Appea","url":"https://stock-news.laohu8.com/highlight/detail?id=2603678690","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603678690?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:55","pubTimestamp":1768452936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2603678611","title":"Mayne Pharma - Grounds Set Out in Notice of Appeal Seek to Challenge Court's Findings Regarding Co's FY25 Ebitda, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2603678611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603678611?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:55","pubTimestamp":1768452936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2603618678","title":"Mayne Pharma Group Ltd - Considering Notice of Appeal and Intends to Vigorously Defend Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2603618678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603618678?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:55","pubTimestamp":1768452936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2603113650","title":"BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603113650","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603113650?lang=en_us&edition=fundamental","pubTime":"2026-01-14 10:34","pubTimestamp":1768358052,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing** Shares of Mayne Pharma MYX.AX slip 1.66% to A$2.96, their lowest since mid-October 2023** Pharma co to cut board's size, says mov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL6N3YF05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2603652142","title":"BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652142","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603652142?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:38","pubTimestamp":1768354689,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To RetireJan 14  - Mayne Pharma Group Ltd MYX.AX:MAYNE PHARMA BOARD CHANGESFRANK CONDELLA, BOARD CHAIR, HAS DECIDED TO RETIREBRUCE ROBINSON HAS BEEN APPOINTED AS NON-EXECUTIVE CHAIR OF BOARDFurther company coverage: MYX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nTUEB675D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2603807656","title":"ASX Preview: Australian Shares Set to Fall Amid Oil Surge; BlueScope Steel to Pay Special Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2603807656","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603807656?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:02","pubTimestamp":1768345321,"startTime":"0","endTime":"0","summary":"Australian shares are poised to fall on Wednesday as surging global oil prices, driven by unrest in Iran and supply uncertainties from Venezuela, heighten investor concerns over energy costs and marke","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BSL.AU","XAO.AU","XKO.AU","BK7129","BK7096","XJO.AU","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2603556716","title":"Mayne Pharma Group Chair to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2603556716","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603556716?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:35","pubTimestamp":1768343739,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group (ASX:MYX) said that Chair Frank Condella has decided to retire from the board, effective Wednesday, according to a same-day Australian bourse filing.Bruce Robinson has been appointed non-executive chair, effective Wednesday, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2603535196","title":"Mayne Pharma Group Ltd - Bruce Robinson Has Been Appointed as Non-Executive Chair of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2603535196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603535196?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:53","pubTimestamp":1768341211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUEB675D2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2593468021","title":"Mayne Pharma Group Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2593468021","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593468021?lang=en_us&edition=fundamental","pubTime":"2025-12-23 11:23","pubTimestamp":1766460228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUE24F4VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2593177775","title":"Mayne Pharma Group Says Net Revenues Fall 5.5% Year on Year  for the Period Between July, November","url":"https://stock-news.laohu8.com/highlight/detail?id=2593177775","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593177775?lang=en_us&edition=fundamental","pubTime":"2025-12-22 10:35","pubTimestamp":1766370944,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said that during the period from July to November, its net revenues were AU$165 million, falling 5.5% from the same period in the previous year, according to a Monday Australian bourse filing.The Women's Health sector was flat at $50.8 million while dermatology was down 12% to $37.1 million over the same period. The Women's Health sector saw continued growth with demand for total prescriptions showing continued volume growth through the first five months of fiscal year 2026.Underlying earnings before interest, taxes, depreciation, and amortization for the period was AU$11.5 million compared to the prior-year EBITDA of AU$22.4 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2593171449","title":"BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171449","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593171449?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:58","pubTimestamp":1766365085,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26Dec 22  - Mayne Pharma Group Ltd MYX.AX:UNDERLYING EBITDA FOR FIRST 5 MONTHS OF FY26 WAS A$11.5MNET REVENUES WERE A$165 MILLION FOR FIRST 5 MONTHS OF FY26Further company coverage: MYX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2593756291","title":"Mayne Pharma Group -  Net Revenues Were a$165 Mln for First 5 Months of FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593756291?lang=en_us&edition=fundamental","pubTime":"2025-12-22 05:44","pubTimestamp":1766353491,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251221:nFWN3XR02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2593175621","title":"Mayne Pharma Group - Underlying Ebitda for First 5 Months of FY26 Was a$11.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2593175621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593175621?lang=en_us&edition=fundamental","pubTime":"2025-12-22 05:44","pubTimestamp":1766353491,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251221:nFWN3XR02U:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":125,"code":"91000000","status":"200"}]}}